| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |